TY - JOUR
T1 - Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis
AU - Fabriek, Babs O
AU - Møller, Holger J
AU - Vloet, Rianka P M
AU - van Winsen, Lisa M
AU - Hanemaaijer, Roeland
AU - Teunissen, Charlotte E
AU - Uitdehaag, Bernard M J
AU - van den Berg, Timo K
AU - Dijkstra, Christine D
PY - 2007/7
Y1 - 2007/7
N2 - The scavenger receptor CD163 is selectively expressed on tissue macrophages and human monocytes. CD163 has been implicated to play a role in the clearance of hemoglobin and in the regulation of cytokine production by macrophages. Membrane CD163 can be cleaved by matrix metalloproteinases (MMP) resulting in soluble CD163 (sCD163). In the present report the shedding of CD163 was investigated in multiple sclerosis (MS). An upregulation of plasma sCD163 and a down regulation of membrane CD163 in MS patients compared to healthy controls was observed. The levels of plasma sCD163 correlated with plasma MMP-9 levels in controls, but not in MS patients. Moreover, evidence was obtained for CD163-cleaving MMP activity in plasma of MS patients. Finally, the increased proteolytic shedding of CD163 correlated to reduced plasma levels of circulating inflammatory cytokines. Collectively, our results provide evidence for proteolytic shedding of CD163 in MS and suggest a possible link to cytokine production.
AB - The scavenger receptor CD163 is selectively expressed on tissue macrophages and human monocytes. CD163 has been implicated to play a role in the clearance of hemoglobin and in the regulation of cytokine production by macrophages. Membrane CD163 can be cleaved by matrix metalloproteinases (MMP) resulting in soluble CD163 (sCD163). In the present report the shedding of CD163 was investigated in multiple sclerosis (MS). An upregulation of plasma sCD163 and a down regulation of membrane CD163 in MS patients compared to healthy controls was observed. The levels of plasma sCD163 correlated with plasma MMP-9 levels in controls, but not in MS patients. Moreover, evidence was obtained for CD163-cleaving MMP activity in plasma of MS patients. Finally, the increased proteolytic shedding of CD163 correlated to reduced plasma levels of circulating inflammatory cytokines. Collectively, our results provide evidence for proteolytic shedding of CD163 in MS and suggest a possible link to cytokine production.
KW - Adolescent
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Animals
KW - Antigens, CD/blood
KW - Antigens, Differentiation, Myelomonocytic/blood
KW - Cell Line, Transformed
KW - Cricetinae
KW - Cricetulus
KW - Cytokines/metabolism
KW - Enzyme Inhibitors/pharmacology
KW - Enzyme-Linked Immunosorbent Assay/methods
KW - Female
KW - Humans
KW - Hydrocortisone/metabolism
KW - Male
KW - Matrix Metalloproteinase 2/metabolism
KW - Matrix Metalloproteinase 9/metabolism
KW - Middle Aged
KW - Multiple Sclerosis/blood
KW - Receptors, Cell Surface/blood
KW - Statistics, Nonparametric
KW - Transfection/methods
U2 - 10.1016/j.jneuroim.2007.04.016
DO - 10.1016/j.jneuroim.2007.04.016
M3 - Article
C2 - 17537523
SN - 0165-5728
VL - 187
SP - 179
EP - 186
JO - Journal of Neuroimmunology
JF - Journal of Neuroimmunology
IS - 1-2
ER -